Open Access Green as soon as Postprint is submitted to ZB.
Pharmacological targeting of the actin cytoskeleton to drive endocrinogenesis.
Trends Pharmacol. Sci. 41, 384-386 (2020)
In vitro generation of insulin-secreting beta cells from human pluripotent stem cells (hPSCs) opens new avenues for treating and modeling diabetes. Hogrebe and colleagues established a new 2D differentiation protocol where they targeted the cytoskeleton pharmacologically for controlled endocrine induction and generation of hPSC-derived beta cells with improved function.
Edit extra informations Login
Publication type Article: Journal article
Document type Other: Opinion
Keywords Actin ; Beta Cells ; Endocrine Progenitors ; Latrunculin A ; Pancreatic Progenitors ; Stem Cells; Beta-cells; In-vitro
ISSN (print) / ISBN 0165-6147
Quellenangaben Volume: 41, Issue: 6, Pages: 384-386
Publisher Cell Press
Publishing Place Amsterdam
Reviewing status Peer reviewed